Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Tozadenant

NCT03212313 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

20

Enrollment

INDUSTRY

Sponsor class

Stopped New Safety Information

Conditions

Hepatic Impairment

Interventions

DRUG: Tozadenant

Sponsor

Biotie Therapies Inc.

Collaborators

[object Object]